MCADD
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is an inherited metabolic disorder of mitochondrial fatty acid beta-oxidation caused by mutations in the ACADM gene, which encodes the medium-chain acyl-CoA dehydrogenase enzyme. It is autosomal recessive. The enzyme normally catalyzes the first step in oxidizing medium-chain fatty acids (approximately C6 to C12) in the liver and other tissues. Deficiency impairs energy production during fasting, leads to accumulation of medium-chain fatty acids and their metabolites, and reduces ketone body formation.
Most affected individuals present in infancy or early childhood with episodes of hypoketotic hypoglycemia, vomiting, lethargy,
Diagnosis is commonly made by newborn screening using tandem mass spectrometry, which often shows elevated octanoylcarnitine
Management centers on avoiding prolonged fasting and providing regular caloric intake, especially during illness. An emergency
Prognosis varies with early detection and management. MCADD occurs in about 1 in 10,000 to 1 in